logo
Pharma to escape EU tariffs worth €95bn as US aircraft and whiskey will potentially be hit

Pharma to escape EU tariffs worth €95bn as US aircraft and whiskey will potentially be hit

But there could still be a sting in the tail for Ireland, as whiskey and thoroughbred horses are on the proposed list, which might lead to further US retaliation, should they be imposed.
There is a further potential problem for major employers Ryanair, with tariffs proposed against Boeing, with whom the airline has a pipeline of orders worth €30 billion through to 2034.
EU officials stressed at the Berlaymont in Brussels today that this is a "proportionate" response to US President Donald Trump's so-called Liberation Day tariffs against the EU, which total nearly €380 billion – and is in fact barely more than a quarter of that burden.
But they stress that all options remain on the table, including impositions on services, which could hit big tech, social media and streaming platforms.
Tánaiste Simon Harris said in response to the announcement: 'The Government supported the suspension of the EU's previous package of countermeasures in relation to steel and aluminium. This has helped create important space for negotiations.
'These negotiations remain the main focus for both the EU and Ireland. The Commission is fully engaged in discussions with the US. A negotiated solution remains very clearly the goal and the preferred outcome.
'I strongly support this position. This is also the message I have been delivering in all my bilateral contacts with both the US and EU partners.'
At the same time, he added: 'I understand the need for the EU to undertake further internal preparations in case negotiations are unsuccessful. This is a sensible and measured approach.
'It is really important to stress that these measures will not be implemented immediately. There will be a four week consultation period during which the Commission will be seeking the views of Member States as well as of business and other stakeholders in Europe.
'The proposed package is valued at around €95-€100 billion and covers a range of sectors. The list has just been published and we will be analysing it over the coming days.
'I am committed to working with stakeholder, including through the Government Trade Forum to understand the potential impact of these countermeasures on Ireland. As we have done in the past, we will communicate Irish specific concerns to the Commission.'
Mr Harris said: 'I remain in close contact with Commissioner Sefcovic. I will also be continuing my outreach both with the US and with EU colleagues and I am planning to speak with key partners in the days ahead."
Today's tariffs may not be imposed at all - the aim is for a "mutually advantageous negotiated settlement," officials stressed, even as the UK looks set to announce a tariff deal with the United States today.
The EU is "not pursuing a dollar for dollar approach," yet the countermeasures -- which will now go out to EU members and stakeholders for consultations – hit a wide range of industries and products.
There are €10.5 billion tariffs on US aircraft, with processed food, vegetables and fish products hit, which could have implications for Irish Agrifood later, although the application from the EU side here is limited.
The bulk of impositions will go on industrials – including chemicals, automotive (cars and car parts), engines, electrical equipment, machinery and appliances.
Taoiseach Micheál Martin, who met European Commission President Ursula von der Leyen, will be happy that most of Ireland's wish-list has been met, although there are hits to Kentucky bourbon in response to US 25pc tariffs on EU wines and spirits, currently suspended for 90 days.
The €7.2bn tariffs on electrical equipment will hit many devices, screens and monitors, radar, satellite navigation systems and even jukeboxes.
"We want to protect the very important pharmaceutical sector," said an EU official in a press briefing, adding however, that some US healthcare products were on the list, such as syringes.
In all, €1.3 billion of US alcohol is targeted, but this is a tiny proportion of the overall €95 billion, amounting to less than 2pc – and limiting American scope for response, given its attack on EU alcohol already.
There will also be some export restrictions introduced, if member states agree and there is no transatlantic trade deal, which would stifle some areas of the US economy.
The EU said it was concerned to achieve rebalancing of trade, and there was currently "asymmetry" because of the extent of US impositions, paused for now. It was not a matter of retaliation, they said, but of "being prepared for all scenarios".
Litigation against the United States at World Trade Organisation (WTO) level is simultaneously taking place, but this is expected to wither on the vine if trade talks produce a disengagement from Trump's tariff wars and an equitable trading environment.
EU Trade Commissioner Maros Sefcovic is already in touch with US colleagues and both sides probe for an understanding.
On April 2 last, President Trump announced tariffs for EU goods set at 20pc. The US also imposed a tariff of 25pc on all imports of vehicles and car parts.
These were announced in addition to 25pc tariffs on imports of steel, aluminium, and derivative products the US previously put forward in February.
President von der Leyen responded by announcing the preparation of EU countermeasures against the US, if negotiations to remove these tariffs should fail.
On April 9, the US announced a 90-day pause of the EU-specific 20pc tariff, leaving in force a 10pc tariff.
In response to this pause, on April 14, the EU responded by putting on hold planned countermeasures against US tariffs on EU steel and aluminium imports, "to allow space for negotiations'.
Currently, €379 billion of EU exports to the US (or 70pc of EU exports to the US) are subject to new tariffs (including tariffs put on pause) since the second Trump administration took office.
"Already, the US tariffs are raising costs for business, stifling growth, fuelling inflation and heightening economic uncertainty," the EU Commission said as it announced its potential countermeasures today.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US pulling out of UNESCO, state department confirms
US pulling out of UNESCO, state department confirms

RTÉ News​

timea minute ago

  • RTÉ News​

US pulling out of UNESCO, state department confirms

The United States will leave the United Nations' culture and education agency UNESCO, the US state department has confirmed. The move is a blow to the Paris-based agency, founded after World War II to promote peace through international cooperation in education, science, and culture. President Donald Trump took similar steps during his first term, quitting the World Health Organization, the UN Human Rights Council, a global climate change accord and the Iran nuclear deal. Joe Biden reversed those decisions after taking office in 2021, returning the US to UNESCO, the WHO and the climate agreement. With Mr Trump now back in the White House, the US is once again pulling out of these global bodies. The administration has also ordered a 90-day pause on all US foreign assistance to assess alignment with Mr Trump's foreign policy priorities. UNESCO is best known for designating World Heritage Sites, including the Grand Canyon in the United States and the ancient city of Palmyra in Syria. The United States initially joined UNESCO at its founding in1945 but withdrew for the first time in 1984 in protest against alleged financial mismanagement and perceived anti-US bias, returning almost 20 years later in 2003 under President George W Bush, who then said the agency had undertaken needed reforms. UNESCO's full name is the United Nations Educational, Scientific and Cultural Organization. UNESCO officials said the agency was already a lot less dependent on the United States than in the past, but the move would nonetheless impact the agency, with some limited impact on programmes the US was financing. The United States provides about 8% of UNESCO's total budget, down from about 20% at the time Mr Trump first pulled the United States out of the agency.

Wicklow stonemason's table and giftware features in ‘Made Local' campaign
Wicklow stonemason's table and giftware features in ‘Made Local' campaign

Irish Independent

time3 minutes ago

  • Irish Independent

Wicklow stonemason's table and giftware features in ‘Made Local' campaign

Taking pride in creating high-quality and functional tableware and giftware, Hennessy & Byrne work with indigenous Irish stone, such as Connemara Marble, Kilkenny Limestone and Dublin and Wicklow Granite. Building on a family tradition of working with fine marble and granite, which spans more than half a century, their products are entirely designed and handcrafted in their studio, which is open to the public all year round, on the grounds of Russborough House. All Hennessy & Byrne giftware is handcrafted by Eric, a second-generation master stonemason with over 20 years of experience. Working with the finest marble and granite from all over the world, Eric has always had a passion for Irish stone, whether it's the swirling green veins of Connemara Marble, the lustrous black shades of Kilkenny Limestone or the silver flecks of mica characteristic of Wicklow Granite. Being part of this year's Made Local campaign represents a huge boon for the business, as it celebrates the exceptional talent, skill, and creativity of Ireland's designers and makers from studio to shop shelf. With sustainability at its core, the Made Local campaign seeks to increase awareness and appreciation of Irish-made products and support the growth of Ireland's sustainable design and craft industry. During the pandemic, Design & Crafts Council Ireland (DCCI) developed the Made Local initiative to support the Irish design and craft industry, to boost sales and to drive revenue for makers and the retailers that support them. As makers continue to face challenges from the cost of living to soaring energy prices, 'Made Local, Made to Last' highlights the value and longevity of well-crafted products through a nationwide campaign. 'The campaign is a reminder to people that buying locally produced, well-crafted products is much more meaningful, sustainable, and impactful,' a campaign spokesperson said. 'This year, Made Local is calling on retailers from across Ireland to register to become a member of the campaign. 'By joining Made Local retailers across Ireland can show their support for the Irish design and craft industry by stocking beautiful products made in Ireland.'

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms
AstraZeneca unveils $50 billion US investment as pharma tariff threat looms

RTÉ News​

time6 minutes ago

  • RTÉ News​

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the US by 2030, it said, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy. The investment will fund a new drug manufacturing facility in Virginia and expand research and development (R&D) and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, it said in a statement. It will also upgrade the Anglo-Swedish drugmaker's US clinical trial supply network and support ongoing investment in novel medicines. AstraZeneca said the expansion supports its ambition to reach $80 billion in annual revenue by 2030, with half coming from the US. The US accounted for more than 40% of AstraZeneca's annual revenue in 2024, and the company had been prioritising the market - the world's largest, worth $635 billion - before Trump's return to office. The move to scale up its US footprint is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry and seeks to boost domestic manufacturing. The sector has historically been spared from trade disputes. Trump has called on pharma companies to make more of the medicines they sell in the US within the country, rather than importing active ingredients or finished medicines. He is also pushing for prices in the US to fall to what other countries pay. CEO Pascal Soriot announced the plans in Washington, saying he believes that drug prices need to rise elsewhere and "equalise" with other countries effectively contributing more to research and development costs. "The US cannot build or carry the cost of R&D for the entire world," he said. US Commerce Secretary Howard Lutnick's department is leading a probe into pharmaceutical imports that could pave the way for new tariffs. "For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness," said Lutnick in a statement issued by AstraZeneca. While Trump has repeatedly threatened tariffs on the sector, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any levies take effect. The company said that the timing and location of the announcement was linked to the US policy environment, though some of the spending would have occurred regardless so that the infrastructure for future medicines was in place. The pledge is in addition to the $3.5 billion in investments the company announced in November 2024, the statement said. The $50 billion pledge matches the commitment announced by Swiss rival Roche in April and follows new spending plans unveiled this year by Eli Lilly & Co, Johnson & Johnson, Novartis and Sanofi. Also present at the announcement was Virginia State Governor Glenn Youngkin, a vocal Trump ally who has defended the administration's tariff policies. The new Virginia facility - the company's largest single manufacturing investment - will produce active ingredients for AstraZeneca's experimental weight-loss medicines, including its oral GLP-1 candidate and an oral PCSK9 inhibitor for cholesterol management, it said. The company said the investment could create tens of thousands of new jobs, but declined to give specifics. It employs about 18,000 people in the US and has a global workforce of about 90,000. In January it scrapped plans to invest £450m in its vaccine manufacturing plant in northern England, citing a cut in government support. Earlier this month, The Times reported the company was considering moving its stock market listing from London, where it is the exchange's most valuable company worth 159 billion pounds, to the US. The company declined to comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store